Save up -80% on Ivacaftor
Note: this is a drug discount program, not an insurance plan.
2018 Price of Ivacaftor
* price without discount in nearest pharmacy. Price may vary.
We offer free Ivacaftor coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Ivacaftor every time. What are you waiting for? Claim your prescription drug card now!
Ivacaftor volume of distribution
The mean apparent volume of distribution (Vz/F) of ivacaftor after a single dose of 275 mg of Ivacaftor in the fed state was similar for healthy subjects and patients with CF. After oral administration of 150 mg every 12 hours for 7 days to healthy volunteers in a fed state, the mean ( SD) for apparent volume of distribution was 353 (122) L.
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Ivacaftor
Ivacaftor (also known as Kalydeco or VX-770) is a drug for the treatment of cystic fibrosis, developed by Vertex Pharmaceuticals and the Cystic Fibrosis Foundation. FDA approved on January 31, 2012.
Ivacaftor mechanism of action
Cystic fibrosis is caused by any one of several defects in a protein, cystic fibrosis transmembrane conductance regulator, which regulates fluid flow within cells and affects the components of sweat, digestive fluids, and mucus. The defect, which is caused by a mutation in the individual’s DNA, can be in any of several locations along the protein, each of which interferes with a different function of the protein. One mutation, G551D, lets the CFTR protein reach the epithelial cell surface, but doesn’t let it transport chloride through the ion channel. Ivacaftor is a potentiator of the CFTR protein. The CFTR protein is a chloride channel present at the surface of epithelial cells in multiple organs. Ivacaftor facilitates increased chloride transport by potentiating the channel-open probability (or gating) of the G551D-CFTR protein.
Dosage forms of Ivacaftor
Vertex Pharmaceuticals (Canada) Incorporated
Humans and other mammals
Indication of Ivacaftor
For the treatment of cystic fibrosis (CF) in patients age 6 years and older who have a G551D mutation in the CFTR gene.
Toxicity of Ivacaftor
There have been no reports of overdose with Ivacaftor. The highest single dose used in a clinical study was 800 mg in a solution formulation without any treatment-related adverse events.
RX24 Drugs Disclaimer: before buying a Ivacaftor on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.